feed,title,long_url,short_url
Benzinga,"On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial",https://benzinga.com/general/biotech/22/01/25182357/on-positive-virology-data-sab-biotherapeutics-covid-19-drug-to-move-to-phase-3-in-nih-activ-2-tri,https://bit.ly/3u2qvKG
Benzinga,Ionis' Eplontersen Receives FDA Orphan Drug Status For Misfolded Protein Disorder,https://benzinga.com/general/biotech/22/01/25182558/ionis-eplontersen-receives-fda-orphan-drug-status-for-misfolded-protein-disorder,https://bit.ly/33Z70Ia
